Treatment of Hemangioma with High Dose Oral Corticosteroid

  • M. Sjabaroeddin Lubis Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Zakaria Siregar Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
  • Nuraida Nuraida Department of Child Health, University of Sumatera Utara Medical School/H. Adam Malik Hospital, Medan, North Sumatera
Keywords: hemangioma, high dose corticosteroid, cavernous hemangioma, hard palate

Abstract

A case with diagnosis of cavernous hemangioma in the hard palate was
successfully treated with 4-6 weeks of high dosage prednisone (2-3 mg/kgBW /day).
Diagnosis of cavernous hemangioma was established based on physical examination.
There was a mass in the hard palate, continuously bleeding and difficult to treat. After
4-6 weeks treatment, the hemangioma regressed and never recurrent anymore.

References

1. Behrmann RE, Kliegman RM, Nelson WE et al. Nelson Textbook of pediatrics; 15th ed. Philadelphia: WB Saunders company, 1996;1477: 1838-9.
2. Locobucci JJ. Hemangioma. In: Gay SM, Gery L, Hoenigke V Eds. Decision making in plastic surgery. St Louis: BC Decker,l993: 36-7.
3. Raffensperger JG. Swenson's Pediatrics surgery; 5th ed. New York: Appleton & Lange 1990: 158-62.
4. Thompson HG. Hemangioma, lymphangioma, and arteriovenous fistula. In: Grabb WC, S.mith JW eds. Plastic surgery, 3rd ed. Boston: Little Brown and company 1979: 518-25.
5. Rowe Ml, C"Neill JA, Grosfeld JL, Fonkalsru EW. Essentials of pediatric surgery. St. Louis, Baltimore: Mosby I 995: 793-803.
6. Mulliken JB, Young AE. Vascular birthmarks hemangiomas and malformation. Philadelphia: WFl Saunders company I 988: 85-97.
How to Cite
1.
Lubis M, Siregar Z, Nuraida N. Treatment of Hemangioma with High Dose Oral Corticosteroid. PI [Internet]. 1 [cited 26Apr.2024];39(5-6):177-0. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1778
Received 2018-02-13
Accepted 2018-02-13